Zobrazeno 1 - 10
of 352
pro vyhledávání: '"Anti-Bacterial Agents/pharmacology"'
Autor:
Katherine Keenan, Kathryn J. Fredricks, Mary Abed Al Ahad, Stella Neema, Joseph R. Mwanga, Mike Kesby, Martha F. Mushi, Annette Aduda, Dominique L. Green, Andy G. Lynch, Sarah I. Huque, Blandina T. Mmbaga, Hannah Worthington, Catherine Kansiime, Emmanuel Olamijuwon, Nyanda E. Ntinginya, Olga Loza, Joel Bazira, Antonio Maldonado-Barragán, V Anne Smith, Arun Gonzales Decano, John Njeru Mwaniki, Alison Sandeman, John Stelling, Alison Elliott, David Aanensen, Stephen H. Gillespie, Gibson Kibiki, Wilber Sabiiti, Derek J. Sloan, Benon B. Asiimwe, John Kiiru, Stephen E. Mshana, Matthew T. G. Holden, HATUA Consortium
Funding: The Holistic Approach to Unravel Antibacterial Resistance in East Africa is a Global Context Consortia Award (MR/S004785/1) funded by the National Institute for Health Research, Medical Research Council, and the Department of Health and Soci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6373ad904c13fe179e1861feeeda388a
https://hdl.handle.net/10023/27861
https://hdl.handle.net/10023/27861
Autor:
Roel P J Willems, Karin van Dijk, Maria J G T Vehreschild, Lena M Biehl, Johannes C F Ket, Sharon Remmelzwaal, Christina M J E Vandenbroucke-Grauls
Publikováno v:
Willems, R P J, van Dijk, K, Vehreschild, M J G T, Biehl, L M, Ket, J C F, Remmelzwaal, S & Vandenbroucke-Grauls, C M J E 2023, ' Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers : a systematic review and meta-regression analysis ', The Lancet Infectious Diseases, vol. 23, no. 6, pp. 719-731 . https://doi.org/10.1016/S1473-3099(22)00811-8
The Lancet Infectious Diseases. Lancet Publishing Group
The Lancet Infectious Diseases, 23(6), 719-731. Lancet Publishing Group
The Lancet Infectious Diseases. Lancet Publishing Group
The Lancet Infectious Diseases, 23(6), 719-731. Lancet Publishing Group
Background: Carriers of multidrug-resistant bacteria are at risk of infections with these bacteria; the precise size of this risk is unclear. We aimed to quantify the effect of gut colonisation on subsequent risk of infection with multidrug-resistant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::529c973f0059c91ecd44565fab5b38fc
https://pure.au.dk/portal/da/publications/incidence-of-infection-with-multidrugresistant-gramnegative-bacteria-and-vancomycinresistant-enterococci-in-carriers(6df2e7ef-c64e-4a52-9ec4-d0c5f6ebfbe1).html
https://pure.au.dk/portal/da/publications/incidence-of-infection-with-multidrugresistant-gramnegative-bacteria-and-vancomycinresistant-enterococci-in-carriers(6df2e7ef-c64e-4a52-9ec4-d0c5f6ebfbe1).html
Autor:
Jay Patel, Anne Harant, Genevie Fernandes, Ambele Judith Mwamelo, Wolfgang Hein, Denise Dekker, Devi Sridhar
Publikováno v:
Patel, J, Harant, A, Fernandes, G, Mwamelo, A J, Hein, W, Dekker, D & Sridhar, D 2023, ' Measuring the global response to antimicrobial resistance, 2020-21 : a systematic governance analysis of 114 countries ', The Lancet Infectious Diseases, vol. 23, no. 6, pp. 706-718 . https://doi.org/10.1016/S1473-3099(22)00796-4
BACKGROUND: Understanding strategic commitments and policy responses to overcome antimicrobial resistance at the national, regional, and global levels is required to evaluate current progress and direct future planning. National action plans (NAPs) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbdf43a1d734d7fcadf7c7e20d999eae
https://www.pure.ed.ac.uk/ws/files/323887557/Measuring_the_global_response_to_antimicrobial_resistance_2020_21.pdf
https://www.pure.ed.ac.uk/ws/files/323887557/Measuring_the_global_response_to_antimicrobial_resistance_2020_21.pdf
Autor:
Eduarda Batista Logrado, Gabriela de Souza Lima, Ellen Ágatta Marinho Silva, Romário Versailles Silva Costa, Arianne Alexandre de Moraes Arrais, Priscila Xavier de Araujo
Este é um trabalho que objetiva validar o e-book “Farmacoterapia: antimicrobianos utilizados na atenção básica e em pequenas cirurgias”. Trata-se de uma pesquisa metodológica que objetiva a construção e validação de um e-book que será u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cb849a2e7104d2d3bbf5729059faf0c
Publikováno v:
International Journal of Infectious Diseases. 116:397-402
BACKGROUND: Otomastoiditis caused by Mycobacterium abscessus is rare, but its incidence has increased over the past decades and its optimal treatment remains unknown. This study aims to summarise the clinical and therapeutic features and find charact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od________83::3e9dc8ee47442f433cc92cce88a262e2
https://cris.maastrichtuniversity.nl/en/publications/471003d9-a679-427b-8e94-6d419716670c
https://cris.maastrichtuniversity.nl/en/publications/471003d9-a679-427b-8e94-6d419716670c
Publikováno v:
Journal of Neural Transmission. 129:773-804
The novel antibiotic-exploiting strategy in the treatment of Alzheimer's (AD) and Parkinson's (PD) disease has emerged as a potential breakthrough in the field. The research in animal AD/PD models provided evidence on the antiamyloidogenic, anti- inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30f8896fb3277f958a9e9d458d2bed5f
https://doi.org/10.1007/s00702-021-02457-2
https://doi.org/10.1007/s00702-021-02457-2
Autor:
Mitra, Pirhaghi, Zahra, Najarzadeh, Faezeh, Moosavi-Movahedi, Mahshid, Shafizadeh, Fatemeh, Mamashli, Deyhim, Atarod, Atiyeh, Ghasemi, Dina, Morshedi, Ali Akbar, Meratan, Daniel E, Otzen, Ali Akbar, Saboury
Publikováno v:
Pirhaghi, M, Najarzadeh, Z, Moosavi-Movahedi, F, Shafizadeh, M, Mamashli, F, Atarod, D, Ghasemi, A, Morshedi, D, Meratan, A A, Otzen, D E & Saboury, A A 2023, ' The anti-platelet drug ticlopidine inhibits FapC fibrillation and biofilm production : Highlighting its antibiotic activity ', Biochimica et Biophysica Acta-Proteins and Proteomics, vol. 1871, no. 2, 140883 . https://doi.org/10.1016/j.bbapap.2022.140883
Multidrug resistance of bacteria and persistent infections related to biofilms, as well as the low availability of new antibacterial drugs, make it urgent to develop new antibiotics. Here, we evaluate the antibacterial and anti-biofilm properties of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c783bae4f81abd4bae5ec230b48fbfc
https://pure.au.dk/portal/da/publications/the-antiplatelet-drug-ticlopidine-inhibits-fapc-fibrillation-and-biofilm-production(73eeea64-02c1-4f5a-b527-d61f3565bb38).html
https://pure.au.dk/portal/da/publications/the-antiplatelet-drug-ticlopidine-inhibits-fapc-fibrillation-and-biofilm-production(73eeea64-02c1-4f5a-b527-d61f3565bb38).html
Autor:
Aiva Plotniece, Arkadij Sobolev, Claudiu T. Supuran, Fabrizio Carta, Fredrik Björkling, Henrik Franzyk, Jari Yli-Kauhaluoma, Koen Augustyns, Paul Cos, Linda De Vooght, Matthias Govaerts, Juliana Aizawa, Päivi Tammela, Raivis Žalubovskis
Publikováno v:
Journal of enzyme inhibition and medicinal chemistry
Plotniece, A, Sobolev, A, Supuran, C T, Carta, F, Björkling, F, Franzyk, H, Yli-Kauhaluoma, J, Augustyns, K, Cos, P, De Vooght, L, Govaerts, M, Aizawa, J, Tammela, P & Žalubovskis, R 2023, ' Selected strategies to fight pathogenic bacteria ', Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 38, no. 1, 2155816 . https://doi.org/10.1080/14756366.2022.2155816
Plotniece, A, Sobolev, A, Supuran, C T, Carta, F, Björkling, F, Franzyk, H, Yli-Kauhaluoma, J, Augustyns, K, Cos, P, De Vooght, L, Govaerts, M, Aizawa, J, Tammela, P & Žalubovskis, R 2023, ' Selected strategies to fight pathogenic bacteria ', Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 38, no. 1, 2155816 . https://doi.org/10.1080/14756366.2022.2155816
Natural products and analogues are a source of antibacterial drug discovery. Considering drug resistance levels emerging for antibiotics, identification of bacterial metalloenzymes and the synthesis of selective inhibitors are interesting for antibac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2f0aaa0320d8ae239d3de27617bf542
https://repository.uantwerpen.be/docstore/d:irua:15617
https://repository.uantwerpen.be/docstore/d:irua:15617
Autor:
Faustinos Tatenda Takawira, Johann D. D. Pitout, Gaetan Thilliez, Tapfumanei Mashe, Ana Victoria Gutierrez, Robert A. Kingsley, Gisele Peirano, Jorge Matheu, Stanley Munyaradzi Midzi, Lusubilo Witson Mwamakamba, David L. Gally, Andrew Tarupiwa, Leckson Mukavhi, Marthie M. Ehlers, Sekesai Mtapuri-Zinyowera, Marleen M. Kock
Publikováno v:
Takawira, F T, Pitout, J D D, Thilliez, G, Mashe, T, Gutierrez, A V, Kingsley, R A, Peirano, G, Matheu, J, Midzi, S M, Mwamakamba, L W, Gally, D L, Tarupiwa, A, Mukavhi, L, Ehlers, M M, Mtapuri-Zinyowera, S & Kock, M M 2022, ' Faecal carriage of ESBL producing and colistin resistant Escherichia coli in avian species over a 2-year period (2017-2019) in Zimbabwe ', Frontiers in Cellular and Infection Microbiology, vol. 12, 1035145 . https://doi.org/10.3389/fcimb.2022.1035145
IntroductionExtended spectrum beta-lactamase (ESBL) producing Escherichia coli have become widespread among food producing animals. These strains serve as a reservoir of antibiotic resistance genes (ARGs) and act as a possible source of infection to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46ec85361ef8c3f66b9ae0be2344f824
https://doi.org/10.3389/fcimb.2022.1035145
https://doi.org/10.3389/fcimb.2022.1035145
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 23; Pages: 15306
Funding Information: This work was supported by Project BIOSAFE funded by FEDER through the Programa Operacional Factores de Competitividade—COMPETE and by Fundação para a Ciência e a Tecnologia (FCT, Portugal)—Grant LISBOA-01-0145-FEDER-03071
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1d93d8c131f33a6f00f6789215fec19
https://hdl.handle.net/10362/148011
https://hdl.handle.net/10362/148011